Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
NervGen Completes Dosing of First Subject in Subacute Cohort of its Phase 1b/2a Clinical Trial of NVG-291 in Spinal Cord Injury
-
FTI Delta Strengthens Telecommunications Practice with Two Senior Hires
-
First National Corporation Reports Fourth Quarter and Annual 2024 Financial Results
-
Ballard Announces Q4 and Full Year 2024 Results Conference Call
-
AGCO REPORTS FOURTH QUARTER AND 2024 FULL YEAR RESULTS
-
DeFi Technologies Announces Attendance and Platinum Sponsorship of the Capital Markets Forum Riyadh 2025
-
23rd Annual South Metro Development Outlook Conference (SMDO25) Returns With Visionary Agenda To Spur Economic Growth
-
VR Resources Provides Exploration Update on Silverback and Empire Projects, Ontario
-
MADISON SQUARE GARDEN ENTERTAINMENT CORP. REPORTS FISCAL 2025 SECOND QUARTER RESULTS
-
Y-mAbs to Present at the Oppenheimer 35ᵗʰ Annual Life Sciences Conference
-
CME Group Declares Quarterly Dividend
-
Lewis Pugh, Renowned Endurance Swimmer and UN Patron of the Oceans, to Deliver Closing Keynote Address at Optimove’s 2025 Connect Conference
-
Washington Metropolitan Area Transit Authority awards contract to NFI subsidiary New Flyer for up to 500 low- and zero-emission Xcelsior® buses
-
Insurance Industry Exploits California Wildfire Disaster to Promote Deregulation in Congress, Consumer Watchdog Says
-
Belden Reports Fourth Quarter and Full Year 2024 Results
-
Jones Soda Secures new USD 5 Million Credit Facility to Fuel Sales Growth in 2025
-
Affordable Excellence: Hyundai Santa Fe Named Best Car of 2025 by Cars.com
-
Garrett Motion to Hold Fourth Quarter 2024 Financial Results Conference Call on Thursday February 20, 2025
-
Suburban Propane Partners, L.P. Announces First Quarter Results
-
Intercontinental Exchange Reports Strong Full Year 2024 Results
-
Relmada Therapeutics Acquires Potential Therapy for Tourette Syndrome from Asarina Pharma AB
-
Ingles Markets, Incorporated Reports Results for the First Quarter of Fiscal 2025
-
SIGULER GUFF'S TACTICAL CREDIT STRATEGY POSTS RECORD Q4 DEAL ACTIVITY
-
Realbotix to Release its Q1-2025 Financial Results on February 13, 2025
-
Latch Announces New Leadership Team
-
Palatin Completes Phase 2 Obesity Study With MC4R Bremelanotide Plus GLP-1/GIP Tirzepatide
-
Lynn University and Related Ross partner to create student internships and employment opportunities
-
Mohegan Invites You to Join Its First Quarter Fiscal 2025 Operating Results Conference Call
-
Graham Corporation Announces Transition to Strengthen Core Leadership Team and Support Continued Growth
-
Human Affairs International of California Earns Full Accreditation from the National Committee for Quality Assurance
-
Acadian Asset Management Inc. Reports Financial and Operating Results for the Fourth Quarter Ended December 31, 2024
-
Pagaya Announces Forward Flow Agreement with Blue Owl Managed Funds to Purchase up to $2.4 Billion of Consumer Loans Originated on the Pagaya Network
-
Distribution Solutions Group Announces Timing for Fourth Quarter and Fiscal Year 2024 Results and Conference Call
-
Gannett Schedules Fourth Quarter 2024 Results
-
Warner Music Group Corp. Reports Results for Fiscal First Quarter Ended December 31, 2024
-
Trinity Biotech Reports Landmark First-Day Accuracy Gains in CGM Pre-Pivotal Trial
-
Quantum Biopharma Licensee Celly Nutrition Retains Leading New York Investment Bank to Advise on Capital Raise and Possible Initial Public Offering Following Highly Positive Results from unbuzzd™ Cl
-
Company Clears All Outstanding Cashless Warrants from December Capital Raise
-
ZenaTech’s ZenaDrone Starts Testing its High-Density Batteries to Extend Flight Time for ZenaDrone 1000 Drone for US Defense Applications
-
Capital Clean Energy Carriers Corp. Announces Fourth Quarter 2024 Financial Results
-
Dragonfly Energy Appoints AdvisIRy Partners as its Investor Relations Firm
-
MasterCraft Boat Holdings, Inc. Reports Fiscal 2025 Second Quarter Results
-
CoreCard Corporation Schedules Fourth Quarter 2024 Earnings Release and Conference Call
-
Atsena Therapeutics to Present ATSN-201 Safety and Efficacy Data at The Macula Society’s 48th Annual Meeting
-
Squirro drives almost 60% annual growth through acquisitions, partnerships and technology enhancements
-
Middlefield Canadian Income PCC: Net Asset Value(s)
-
AGF Management Limited - Normal Course Issuer Bid
-
Alliance Witan PLC - Net Asset Value
-
Aclarion Announces Northwestern Medicine as First CLARITY Trial Site
-
Calian Signs over $50M in Defence Contracts in Q1
